Conference Speakers
Cultural Speakers
Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.
At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:
Dr. Speakers Full Name
Speaker Credentials
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization and in 2008 sat for and passed the exam administered by the International Board of Lactation Consultant Examiners. As an International Board Certified Lactation Consultant, she now
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization text text text text more name mulder first became interested in breastfeeding in the year 2000, when she became.
Dr. Speakers Full Name
Speaker Credentials
Speakers (5191)
He obtained his medical degree at the Universidad de Costa Rica and completed his Medical Oncology residency program at the same university in 2009. He then pursued a Thoracic Oncology Fellowship at Hôpital Notre-Dame from the Centre Hospitalier de l’Université de Montréal (CHUM) in Montreal, Canada.
He returned to Costa Rica joining the faculty at Hospital San Juan de Dios and becoming a pre-graduate and post-graduate professor at the Universidad de Costa Rica. He is the director and leading investigator for Costa Rica of several international clinical trials at CIMCA.
He is member of the Asociación Costarricense de Oncología Médica (ACOMED), Consorcio Latinoamericano para la Investigación del Cáncer de Pulmón (CLICaP), Oncology Latin America Association (OLA), ASCO, ESMO, and IASLC.
He has co-authored numerous abstracts and peer-reviewed publications. His interests include translational medicine, molecular biology, targeted therapies, and immune-oncology applied to thoracic, gastrointestinal, and breast oncology among others.
Annalisa Trama, is the Director of the Evaluative Epidemiology Unit at the Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy, where she also serves as Coordinator of the INT Institutional Strategic Research Priority on rare cancers and complexity in oncology.
Her research activities focus on rare cancers and adolescent and young adult cancers. She is an expert in population-based research including population-based cancer registries and administrative dataset. She was a founder of RARECARE (surveillance of rare cancers in Europe) which proposed a definition for rare cancer. She was the founder of RARECAREnet Asia, a collaboration between European and Asian population-based cancer registries (CRs) on rare cancers. In the area of rare cancers, she co-coordinated the Joint Action on Rare Cancers (JARC), carried out between 2016 and 2019 within the framework of the Third Health Programme of the European Union (EU) with 34 partners and 18 EU Member States. She coordinates the clinical registry of EURACAN, the European Reference Network on rare adult solid cancers. She was a founder of the first Italian adolescent and young (AYA) cancer survivor cohort and she coordinates the Steering committee of this cohort. She is a member of the Scientific Coordination of EUROCARE (surveillance of cancer patients in Europe).
She is (co)author of more than 100 papers in peer-reviewed medical journals.
Since January 2021 she is chair of the EORTC lung cancer group. She was involved in the EORTC initiative to develop a consensus definition on synchronous oligometastatic NSCLC. She is member of IASLC, AACR, ASCO, ERS, ESMO and ETOP. She is associate editor of the Journal of Thoracic Oncology and editorial board member of the International IASLC Lung Cancer News. She has (co)-authored more than 230 publications and book chapters.
